NCT06246396View on ClinicalTrials.gov

Antihypertensive Mechanisms of Minocycline in Resistant Hypertension

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 8, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Hypertension, Resistant to Conventional Therapy
Interventions
DRUG

Minocycline Hydrochloride

Minocycline Hydrochloride 100 mg twice daily

DRUG

Placebo

Placebo

Trial Locations (1)

32610

RECRUITING

UF Health Cardiology - Heart & Vascular Hospital, Gainesville

All Listed Sponsors
collaborator

Emory University

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Florida

OTHER